Clinical studies recruiting near Zwolle

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Isala, locatie Zwolle · Pfizer · NCT06758401 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Isala · Hoffmann-La Roche · NCT06793215 REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases
Phase 4 · Isala Zwolle · Sint Maartenskliniek · NCT07160231 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Isala, locatie Zwolle · Eli Lilly and Company · NCT06890598 Use of Physiology to Evaluate Procedural Result After PCI CTO
NA · Isala · Isala · NCT04780971 A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Phase 3 · Local Institution - 0298 · Bristol-Myers Squibb · NCT06976216 RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures
NA · Isala Hospital · AgNovos Healthcare, LLC · NCT04796350 Effectiveness of Focal Therapy in Men With Prostate Cancer
NA · Isala klinieken · Radboud University Medical Center · NCT06223295 Minimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer
Phase N/A · Isala Hospital · Maastricht University Medical Center · NCT04486495 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · Isala /ID# 238846 · AbbVie · NCT04928846 Finding Sentinel Lymph Nodes During Mastectomy Using Indocyanine Green (INIGMA Study)
NA · Isala · Isabelle Henskens · NCT07362485 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738 Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC
Phase 2 · Isala Ziekenhuis · Leiden University Medical Center · NCT05393791 Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism
Phase 4 · Isala Klinieken Zwolle · Drahomir Aujesky · NCT04263038 Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment
Phase N/A · Isala · Catharina Ziekenhuis Eindhoven · NCT05405270 Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN)
Phase 2 · Isala ziekenhuizen · Angitia Incorporated Limited · NCT07062588 A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta
Phase 3 · Local Institution - 0195 · Bristol-Myers Squibb · NCT06561386 Evaluating the Safety of Shortened Infusion Times for dIfferent Oncological Immunotherapie
Phase 4 · Isala Hospital · Isala · NCT06031233 National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)
Phase N/A · Isala · PROspective Renal Cancer Cohort Foundation · NCT05326620 A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
Phase 2 · Isala, locatie Zwolle · Eli Lilly and Company · NCT07219173 An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerabilit
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07517263 Statins in Frail Older Patients with Ischemic Stroke or Transient Ischemic Attack - the Prospective Cohort Study
Phase N/A · Isala Klinieken · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT06785740 Early Transcatheter Mitral Valve Repair After Myocardial Infarction
NA · Isala Hospital · Fundación para la Investigación Biosanitaria del Principado · NCT06282042 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL628 in Participants With Earl
Phase 1 · Clinical Site(s) · Denali Therapeutics Inc. · NCT07328451 Direct Superior Approach Versus PosteroLateral Approach in Total Hip Arthroplasty (SPLAsH)
NA · Isala · Isala · NCT06342843 A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET
Phase 3 · Brain Research Center Zwolle · Bristol-Myers Squibb · NCT06976203 Rifampicin Combination Therapy Versus Monotherapy for Staphylococcal Prosthetic Joint Infection
Phase 4 · Stichting Isala Klinieken · Leiden University Medical Center · NCT06172010 A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Tr
Phase 3 · Isala, locatie Zwolle ( Site 1525) · Merck Sharp & Dohme LLC · NCT06312176 Prospective Endoscopic Follow-up of Patients With Submucosal and High Risk Mucosal Esophageal Adenocarcinoma
NA · Isala Clinics · Amsterdam UMC · NCT03222635 A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD
Phase 3 · Isala Klinieken · Hoffmann-La Roche · NCT05878769

Look up another city

Look up another condition